Phage Therapy Market Size, Share, Growth, and Industry Analysis, By Type (DsDNA Bacteriophage,SsDNA Bacteriophage,SsRNA Bacteriophage), By Application (Animal Health,Aquaculture,Agriculture,Food Industry,Human Health), Regional Insights and Forecast to 2034

Detailed TOC of Global Phage Therapy Market Growth (Status and Outlook) 2025-2031

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Phage Therapy Market Size (2020-2031)
2.1.2 Phage Therapy Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Phage Therapy by Country/Region (2020, 2024 & 2031)
2.2 Phage Therapy Segment by Type
2.2.1 DsDNA Bacteriophage
2.2.2 SsDNA Bacteriophage
2.2.3 SsRNA Bacteriophage
2.2.4 Others
2.3 Phage Therapy Market Size by Type
2.3.1 Phage Therapy Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Phage Therapy Market Size Market Share by Type (2020-2025)
2.4 Phage Therapy Segment by Application
2.4.1 Animal Health
2.4.2 Aquaculture
2.4.3 Agriculture
2.4.4 Food Industry
2.4.5 Human Health
2.4.6 Others
2.5 Phage Therapy Market Size by Application
2.5.1 Phage Therapy Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Phage Therapy Market Size Market Share by Application (2020-2025)
3 Phage Therapy Market Size by Player
3.1 Phage Therapy Market Size Market Share by Player
3.1.1 Global Phage Therapy Revenue by Player (2020-2025)
3.1.2 Global Phage Therapy Revenue Market Share by Player (2020-2025)
3.2 Global Phage Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Phage Therapy by Region
4.1 Phage Therapy Market Size by Region (2020-2025)
4.2 Global Phage Therapy Annual Revenue by Country/Region (2020-2025)
4.3 Americas Phage Therapy Market Size Growth (2020-2025)
4.4 APAC Phage Therapy Market Size Growth (2020-2025)
4.5 Europe Phage Therapy Market Size Growth (2020-2025)
4.6 Middle East & Africa Phage Therapy Market Size Growth (2020-2025)
5 Americas
5.1 Americas Phage Therapy Market Size by Country (2020-2025)
5.2 Americas Phage Therapy Market Size by Type (2020-2025)
5.3 Americas Phage Therapy Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Phage Therapy Market Size by Region (2020-2025)
6.2 APAC Phage Therapy Market Size by Type (2020-2025)
6.3 APAC Phage Therapy Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Phage Therapy Market Size by Country (2020-2025)
7.2 Europe Phage Therapy Market Size by Type (2020-2025)
7.3 Europe Phage Therapy Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Phage Therapy by Region (2020-2025)
8.2 Middle East & Africa Phage Therapy Market Size by Type (2020-2025)
8.3 Middle East & Africa Phage Therapy Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Phage Therapy Market Forecast
10.1 Global Phage Therapy Forecast by Region (2026-2031)
10.1.1 Global Phage Therapy Forecast by Region (2026-2031)
10.1.2 Americas Phage Therapy Forecast
10.1.3 APAC Phage Therapy Forecast
10.1.4 Europe Phage Therapy Forecast
10.1.5 Middle East & Africa Phage Therapy Forecast
10.2 Americas Phage Therapy Forecast by Country (2026-2031)
10.2.1 United States Market Phage Therapy Forecast
10.2.2 Canada Market Phage Therapy Forecast
10.2.3 Mexico Market Phage Therapy Forecast
10.2.4 Brazil Market Phage Therapy Forecast
10.3 APAC Phage Therapy Forecast by Region (2026-2031)
10.3.1 China Phage Therapy Market Forecast
10.3.2 Japan Market Phage Therapy Forecast
10.3.3 Korea Market Phage Therapy Forecast
10.3.4 Southeast Asia Market Phage Therapy Forecast
10.3.5 India Market Phage Therapy Forecast
10.3.6 Australia Market Phage Therapy Forecast
10.4 Europe Phage Therapy Forecast by Country (2026-2031)
10.4.1 Germany Market Phage Therapy Forecast
10.4.2 France Market Phage Therapy Forecast
10.4.3 UK Market Phage Therapy Forecast
10.4.4 Italy Market Phage Therapy Forecast
10.4.5 Russia Market Phage Therapy Forecast
10.5 Middle East & Africa Phage Therapy Forecast by Region (2026-2031)
10.5.1 Egypt Market Phage Therapy Forecast
10.5.2 South Africa Market Phage Therapy Forecast
10.5.3 Israel Market Phage Therapy Forecast
10.5.4 Turkey Market Phage Therapy Forecast
10.6 Global Phage Therapy Forecast by Type (2026-2031)
10.7 Global Phage Therapy Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Phage Therapy Forecast
11 Key Players Analysis
11.1 NPO Microgen
11.1.1 NPO Microgen Company Information
11.1.2 NPO Microgen Phage Therapy Product Offered
11.1.3 NPO Microgen Phage Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 NPO Microgen Main Business Overview
11.1.5 NPO Microgen Latest Developments
11.2 Proteon Pharmaceuticals
11.2.1 Proteon Pharmaceuticals Company Information
11.2.2 Proteon Pharmaceuticals Phage Therapy Product Offered
11.2.3 Proteon Pharmaceuticals Phage Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Proteon Pharmaceuticals Main Business Overview
11.2.5 Proteon Pharmaceuticals Latest Developments
11.3 Phagelux
11.3.1 Phagelux Company Information
11.3.2 Phagelux Phage Therapy Product Offered
11.3.3 Phagelux Phage Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Phagelux Main Business Overview
11.3.5 Phagelux Latest Developments
11.4 Intralytix
11.4.1 Intralytix Company Information
11.4.2 Intralytix Phage Therapy Product Offered
11.4.3 Intralytix Phage Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Intralytix Main Business Overview
11.4.5 Intralytix Latest Developments
11.5 Micreos
11.5.1 Micreos Company Information
11.5.2 Micreos Phage Therapy Product Offered
11.5.3 Micreos Phage Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Micreos Main Business Overview
11.5.5 Micreos Latest Developments
11.6 Eliava BioPreparations
11.6.1 Eliava BioPreparations Company Information
11.6.2 Eliava BioPreparations Phage Therapy Product Offered
11.6.3 Eliava BioPreparations Phage Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Eliava BioPreparations Main Business Overview
11.6.5 Eliava BioPreparations Latest Developments
11.7 Locus Biosciences,Inc
11.7.1 Locus Biosciences,Inc Company Information
11.7.2 Locus Biosciences,Inc Phage Therapy Product Offered
11.7.3 Locus Biosciences,Inc Phage Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Locus Biosciences,Inc Main Business Overview
11.7.5 Locus Biosciences,Inc Latest Developments
11.8 Pharmex Group,LLC
11.8.1 Pharmex Group,LLC Company Information
11.8.2 Pharmex Group,LLC Phage Therapy Product Offered
11.8.3 Pharmex Group,LLC Phage Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Pharmex Group,LLC Main Business Overview
11.8.5 Pharmex Group,LLC Latest Developments
11.9 Pherecydes Pharma
11.9.1 Pherecydes Pharma Company Information
11.9.2 Pherecydes Pharma Phage Therapy Product Offered
11.9.3 Pherecydes Pharma Phage Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Pherecydes Pharma Main Business Overview
11.9.5 Pherecydes Pharma Latest Developments
11.10 APS Biocontrol Ltd. (APS)
11.10.1 APS Biocontrol Ltd. (APS) Company Information
11.10.2 APS Biocontrol Ltd. (APS) Phage Therapy Product Offered
11.10.3 APS Biocontrol Ltd. (APS) Phage Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 APS Biocontrol Ltd. (APS) Main Business Overview
11.10.5 APS Biocontrol Ltd. (APS) Latest Developments
11.11 Qingdao Phagepharm Bio-tech
11.11.1 Qingdao Phagepharm Bio-tech Company Information
11.11.2 Qingdao Phagepharm Bio-tech Phage Therapy Product Offered
11.11.3 Qingdao Phagepharm Bio-tech Phage Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Qingdao Phagepharm Bio-tech Main Business Overview
11.11.5 Qingdao Phagepharm Bio-tech Latest Developments
11.12 Fixed-Phage Limited
11.12.1 Fixed-Phage Limited Company Information
11.12.2 Fixed-Phage Limited Phage Therapy Product Offered
11.12.3 Fixed-Phage Limited Phage Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Fixed-Phage Limited Main Business Overview
11.12.5 Fixed-Phage Limited Latest Developments
11.13 Zeptometrix
11.13.1 Zeptometrix Company Information
11.13.2 Zeptometrix Phage Therapy Product Offered
11.13.3 Zeptometrix Phage Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Zeptometrix Main Business Overview
11.13.5 Zeptometrix Latest Developments
11.14 Phage International, Inc.
11.14.1 Phage International, Inc. Company Information
11.14.2 Phage International, Inc. Phage Therapy Product Offered
11.14.3 Phage International, Inc. Phage Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Phage International, Inc. Main Business Overview
11.14.5 Phage International, Inc. Latest Developments
11.15 MicroMir
11.15.1 MicroMir Company Information
11.15.2 MicroMir Phage Therapy Product Offered
11.15.3 MicroMir Phage Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 MicroMir Main Business Overview
11.15.5 MicroMir Latest Developments
11.16 iNtODEWORLD, Inc.
11.16.1 iNtODEWORLD, Inc. Company Information
11.16.2 iNtODEWORLD, Inc. Phage Therapy Product Offered
11.16.3 iNtODEWORLD, Inc. Phage Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 iNtODEWORLD, Inc. Main Business Overview
11.16.5 iNtODEWORLD, Inc. Latest Developments
11.17 NEXTBIOTICS
11.17.1 NEXTBIOTICS Company Information
11.17.2 NEXTBIOTICS Phage Therapy Product Offered
11.17.3 NEXTBIOTICS Phage Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 NEXTBIOTICS Main Business Overview
11.17.5 NEXTBIOTICS Latest Developments
11.18 Armata Pharmaceuticals, Inc.
11.18.1 Armata Pharmaceuticals, Inc. Company Information
11.18.2 Armata Pharmaceuticals, Inc. Phage Therapy Product Offered
11.18.3 Armata Pharmaceuticals, Inc. Phage Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 Armata Pharmaceuticals, Inc. Main Business Overview
11.18.5 Armata Pharmaceuticals, Inc. Latest Developments
11.19 Innophage
11.19.1 Innophage Company Information
11.19.2 Innophage Phage Therapy Product Offered
11.19.3 Innophage Phage Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.19.4 Innophage Main Business Overview
11.19.5 Innophage Latest Developments
11.20 Adaptive Phage Therapeutics
11.20.1 Adaptive Phage Therapeutics Company Information
11.20.2 Adaptive Phage Therapeutics Phage Therapy Product Offered
11.20.3 Adaptive Phage Therapeutics Phage Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.20.4 Adaptive Phage Therapeutics Main Business Overview
11.20.5 Adaptive Phage Therapeutics Latest Developments
11.21 TechnoPhage
11.21.1 TechnoPhage Company Information
11.21.2 TechnoPhage Phage Therapy Product Offered
11.21.3 TechnoPhage Phage Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.21.4 TechnoPhage Main Business Overview
11.21.5 TechnoPhage Latest Developments